4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: October 9, 2012
Period of Report: October 4, 2012
Accession Number: 0001127602-12-028442

View Document ↗ View on SEC.gov ↗